肉制品中的菌体用于控制病原体和腐烂微生物的应用:当前的进展和挑战
Fabrizia Tittarelli1, Noemi Battistelli1, Giuseppe Aprea1
1Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Campo Boario, 64100 Teramo (TE), Italy.
Journal of food protection
|March 5, 2026
概括
菌体 (菌体) 为肉类安全和腐败提供了有针对性的生物控制. 这些病毒对抗抗菌素耐药性 (AMR),但需要在发酵产品中小心使用,以避免破坏有益细菌.
科学领域:
- 食品微生物学 食品微生物学
- 病毒学 病毒学
- 生物技术是生物技术.
背景情况:
- 抗菌素耐药性 (AMR) 需要在肉类生产中找到可持续的替代品.
- 菌体 (菌体) 是感染细菌的病毒,具有作为向生物控制剂的潜力.
- 肉制品拥有复杂的微生物生态系统,影响安全性,质量和保质期.
研究的目的:
- 审查肉类系统中菌体的应用,以确保食品安全和防腐.
- 批判性地综合当前关于菌体在肉类生产和加工中的使用知识.
- 检查肉类工业中菌体的多方面的作用,挑战和未来前景.
主要方法:
- 叙事综述综合现有科学文献.
- 在肉类生产,加工和储存阶段对菌体应用的分析.
- 对致病/破坏细菌和有益的初始培养的影响的评估.
主要成果:
- 菌体可以有效地控制腐烂细菌 (例如,布罗科特里克斯热菌,伪菌). 和病原体 (例如,沙门氏菌种类,李斯特菌单细胞原体,克洛斯特菌种类. ) 的情况.
- 菌体可能破坏发酵肉中的有益的起始培养物,可能导致发酵失败.
- 菌体呈现出一种天然的抗微生物策略,可以提高肉类的安全性和质量.
结论:
- 菌体对肉类的向微生物控制有希望,解决AMR.
- 仔细考虑菌体与初始培养物的相互作用对于发酵肉的应用至关重要.
- 需要进一步的研究和监管评估,以便在肉类安全管理中广泛整合菌体.
相关概念视频
Biological Methods for Microbial Control
1.1K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.1K
Microorganisms in Agriculture and Food industry
1.8K
Microorganisms play a crucial role in agriculture and the food industry, contributing to soil fertility, crop protection, and food production. Their functions range from nitrogen fixation and biopesticide production to fermentation and food preservation, making them indispensable to sustainable farming and food safety.Role in AgricultureNitrogen-fixing bacteria, such as Rhizobium (symbiotic) and Azotobacter (free-living), convert atmospheric nitrogen into ammonia through biological nitrogen...
1.8K
Methods for Controlling Microbial Growth
2.2K
Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...
2.2K
Lytic Cycle of Bacteriophages
78.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.8K
Physical Methods for Controlling Microbial Growth: Temperature
1.4K
Heat is a widely used method to control microbial growth by targeting and denaturing cellular proteins, thereby killing or inactivating microbes. This method's effectiveness is quantified using parameters such as the thermal death point (TDP), thermal death time (TDT), and decimal reduction time (D value). TDP represents the lowest temperature at which all microorganisms in a liquid suspension are eliminated within 10 minutes, whereas TDT is the time necessary to achieve sterilization at a...
1.4K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K


